Stage
Debt - IV | AliveTotal Raised
$17MLast Raised
$1.5M | 9 yrs agoAbout Arcion Therapeutics
Arcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on topical treatments to provide pain relief with convenient application and reduced systemic side effects. Arcion's core technology is based on research which showed that in many neuropathic pain conditions, the signal that triggers pain actually arises at the level of the skin. This finding provides a strong biological rationale for developing topically delivered drugs to target the pain at the source - the pain receptors in the skin. Arcion's product pipeline comprises multiple candidates to treat neuropathic pain.ARC-4558 is a topical 0.1% clonidine gel being developed for the treatment of painful diabetic neuropathy (PDN). It is a clear, water-based, fast-drying gel that provides pain relief that rivals approved oral drugs. ARC-4558 has a minimal side-effect profile with low/undetectable systemic levels of clonidine with over 600 patients treated in clinical trials to date.
Arcion Therapeutics Headquarter Location
2400 Boston Street Suite 330
Baltimore, Maryland, 21224,
United States
410-522-8701
Latest Arcion Therapeutics News
Jun 16, 2017
Anesiva files for bankruptcy after Arcion merger falls through This article was originally published in Scrip 05 Jan 2010 Executive Summary Anesiva is to file for bankruptcy protection after its proposed merger with Arcion Therapeutics, which appeared to be the struggling pharmaceutical company's saviour in August, was terminated. Already Registered? Sign in to continue reading. Your login and/or password information does not match our records. Please try again. Forgot your password? Forgot your password? Enter the email address associated with your account and an email will be sent to you to reset your password. Please enter a valid email address. Unfortunately we've not been able to process this request. Submit Phone (UK & Europe): +44 (20) 337 73737 Phone (APAC): +61 2 8705 6907 New to Scrip? Request a free trial today! Your username does not meet the requirements. An account with that username already exists. Unfortunately we've not been able to process your registration. Please contact support. Register Your login and/or password information does not match our records. Please try again. Forgot your password? Forgot your password? Enter the email address associated with your account and an email will be sent to you to reset your password. Please enter a valid email address. Unfortunately we've not been able to process this request. Submit Phone (UK & Europe): +44 (20) 337 73737 Phone (APAC): +61 2 8705 6907 Authentication.SignIn.HeadSignInHeader Forgot your password? Forgot your password? Enter the email address associated with your account and an email will be sent to you to reset your password. Please enter a valid email address. Unfortunately we've not been able to process this request. Submit Phone (UK & Europe): +44 (20) 337 73737 Phone (APAC): +61 2 8705 6907 UsernamePublicRestriction Sorry - this email domain is not allowed. Sorry - public email accounts are not allowed. Please provide a work email address. An account with that username already exists. Unfortunately we've not been able to process your registration. Please contact support. Register All fields are required. Please make sure you have filled out all fields Please make sure you have filled out all fields Please enter a valid e-mail address Please enter a valid Phone Number Ask your question to our analysts Cancel All fields are required. For multiple recipients, separate email addresses with a semicolon. Please make sure all fields are completed. Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Anesiva files for bankruptcy after Arcion merger falls through Add a personalized message to your email Cancel Send Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe. Sign In To Set a Search Alert Your login and/or password information does not match our records. Please try again. Forgot your password?
Expert Collections containing Arcion Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Arcion Therapeutics is included in 2 Expert Collections, including Diabetes.
Diabetes
1,750 items
Biopharmaceuticals
5,882 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Arcion Therapeutics Patents
Arcion Therapeutics has filed 4 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/21/2011 | 2/24/2015 | Anticonvulsants, Analgesics, Amines, Antidepressants, Peripheral nervous system disorders | Grant | |
Application Date | 2/21/2011 | |||
|---|---|---|---|---|
Grant Date | 2/24/2015 | |||
Title | ||||
Related Topics | Anticonvulsants, Analgesics, Amines, Antidepressants, Peripheral nervous system disorders | |||
Status | Grant |